Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-016092

Chief Financial Officer gave up 7,162 shares (to pay taxes)

  • Chief Financial Officer acquired 25,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ruffo Frank Chief Financial Officer 2020-03-02 Option exercise +25,750 195,117 D
Ruffo Frank Chief Financial Officer 2020-03-02 Shares withheld for taxes −7,162 $1.26 $9,024 187,955 D
Derivatives
Ruffo Frank Chief Financial Officer 2020-03-02 Option exercise · Restricted stock units −25,750 77,250 D
Ruffo Frank Chief Financial Officer 2020-03-02 Grant or award · Employee Stock Option (Right to Buy) +116,160 116,160 D
Ruffo Frank Chief Financial Officer 2020-03-02 Grant or award · Restricted stock units +66,377 66,377 D
Ruffo Frank Chief Financial Officer 2020-03-02 Grant or award · Restricted stock units +33,189 33,189 D
Loading xslF345X03/doc4.xml…